KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Pacira BioSciences (PCRX) over the last 16 years, with Q3 2025 value amounting to $897000.0.

  • Pacira BioSciences' Change in Receivables rose 12173.49% to $897000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 29485.93%. This contributed to the annual value of $7.7 million for FY2024, which is 822.74% up from last year.
  • Pacira BioSciences' Change in Receivables amounted to $897000.0 in Q3 2025, which was up 12173.49% from $9.6 million recorded in Q2 2025.
  • Over the past 5 years, Pacira BioSciences' Change in Receivables peaked at $15.8 million during Q2 2021, and registered a low of -$18.4 million during Q3 2021.
  • For the 5-year period, Pacira BioSciences' Change in Receivables averaged around $1.5 million, with its median value being $897000.0 (2025).
  • Per our database at Business Quant, Pacira BioSciences' Change in Receivables crashed by 96259.97% in 2021 and then surged by 68867.74% in 2023.
  • Quarter analysis of 5 years shows Pacira BioSciences' Change in Receivables stood at $13.5 million in 2021, then tumbled by 63.52% to $4.9 million in 2022, then soared by 74.56% to $8.6 million in 2023, then skyrocketed by 47.12% to $12.7 million in 2024, then plummeted by 92.91% to $897000.0 in 2025.
  • Its Change in Receivables was $897000.0 in Q3 2025, compared to $9.6 million in Q2 2025 and -$8.6 million in Q1 2025.